---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-086669"
form_type: "8-K"
ticker: "PGEN"
cik: "0001356090"
company_name: "PRECIGEN, INC."
filed_at: "2025-09-03T23:59:59+00:00"
generated_at: "2026-05-17T08:28:07.999755+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Precigen secures up to $125M non-dilutive senior secured loan financing from Pharmakon

## Summary
- $100M funded at close; $25M delayed draw available through June 2027; matures Sept 2030.
- Interest at three-month SOFR (3.75% floor) + 6.50%, payable quarterly; amortization begins Sept 2028.
- Proceeds to support U.S. commercialization of PAPZIMEOS and potential expansion into international and pediatric indications.
- Loan is senior secured by substantially all U.S. assets, including IP; customary covenants and events of default.
- CFO states strengthening balance sheet provides financial flexibility as company enters projected significant growth period.

## SEC filing metadata
- accession: 0001104659-25-086669
- form_type: 8-K
- ticker: PGEN
- cik: 0001356090
- company_name: PRECIGEN, INC.
- filed_at: 2025-09-03T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356090/000110465925086669/0001104659-25-086669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356090/000110465925086669/tm2524946d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-086669
- JSON: https://secwatch.observer/filing/0001104659-25-086669.json
- Plain text: https://secwatch.observer/filing/0001104659-25-086669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.